AKT1 and lung carcinoma: In the KEGG enrichment, Pathways associated with lung cancer and immunity and more enriched in 14 potential targets were PI3K–Akt pathway, MAPK signaling pathway, Non-small cell lung cancer.HSP90AA1, EGFR, MYC, VEGFA, CCND1, MAPK1, AKT1, RELA, CDKN1A, IL2 and TP53 targets are enriched in the PI3K–Akt pathway.